Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Administration of Haploidentical Donor T Cells Transduced With the Inducible Caspase-9 Suicide Gene

NCT01494103 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT01494103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01494103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Administration of Haploidentical Donor T Cells Transduced With the Inducible Caspase-9 Suicide Gene
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Active, not recruiting
Start date
November 30, 2011
Completion date
May 31, 2029
Enrollment
15 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myeloid leukemia, chronic myelogenous leukemia, epstein barr virus infection, familial hemophagocytic lymphohistiocytosis, hemophagocytic lymphohistiocytosis, hemophagocytic syndrome, myelodysplastic syndrome, non hodgkin lymphoma, x-linked lymphoproliferative disease